A null difference in average birth weight does not necessarily contradict an association with being small for gestational age. Historical reports from the IDEAL study show why prenatal methamphetamine research must preserve the growth measure, comparison population and follow-up interval rather than compress every finding into “smaller babies.”
What did the birth study measure?
Nguyen and colleagues compared 204 methamphetamine-exposed infants with 3,501 unexposed infants among 3,705 consenting mother–infant pairs. Exposure was classified by maternal report and/or confirmatory meconium toxicology. Both groups included other prenatal substance exposures.
These exposure classifications are broader than a verified dose on a particular gestational day. They support a group comparison, but cannot reconstruct a fetal concentration-time curve or identify a precise period of susceptibility for an individual infant.
How could one growth result be positive and another null?
The adjusted small-for-gestational-age association had an odds ratio of 2.05 (95% confidence interval 1.24–3.37). The adjusted birth-weight comparison was not statistically significant (p=0.154). Models included prenatal care, socioeconomic and maternal factors and tobacco, alcohol and marijuana exposure.
Average weight and a gestational-age-based classification ask different questions. A group mean summarizes the center of a distribution. A size classification considers a threshold in relation to gestational age. Neither result should erase the other, and an odds ratio is not a statement that every exposed infant was small.
Did the later follow-up use all 3,705 infants?
No. Zabaneh and colleagues reported a longitudinal cohort of 412 children, including 204 exposed and 208 matched comparisons. Growth analyses included 351 children attending at least two of three annual visits.
The birth cohort, enrolled follow-up cohort and analyzed follow-up sample are distinct denominators. Treating every later measurement as if it came from all infants in the birth comparison would overstate the evidence. Repeated measurements within a child also do not turn that child into multiple independent participants.
What persisted through age three?
The adjusted height trajectory was lower in the exposed group: comparison children averaged 0.63 cm taller over the trajectory (standard error 0.27 cm; p=0.021). Weight, head-circumference and weight-for-length trajectories did not differ significantly.
The reported average trajectory difference is not a forecast of adult height. It does not show that the gap widened continuously or that every growth domain was impaired. A standard error describes uncertainty in an estimated average; it is not the spread of all children’s heights.
Can these observations establish a mechanism or diagnosis?
Neither report randomly assigned prenatal exposure. Adjusting for measured co-exposures and social factors improves the analysis without eliminating every alternative explanation. Gestational dating, exposure classification and retention remain relevant to interpretation.
The growth measurements also do not themselves diagnose developmental delay, establish later cardiovascular disease or prove a placental mechanism. Those claims require their own outcomes and evidence. For an individual review, the actual growth chart, gestational assessment, maternal history and subsequent clinical course remain necessary.
The appropriate account is specific: one historical study found an adjusted size-for-gestational-age association alongside a birth-weight null, and a smaller follow-up cohort found a modest height-trajectory difference alongside several null trajectories. This is research commentary, not individualized pregnancy or pediatric advice.
Sources
Nguyen D et al. Intrauterine growth of infants exposed to prenatal methamphetamine: results from the infant development, environment, and lifestyle study. Journal of Pediatrics. 2010;157(2):337–339. doi:10.1016/j.jpeds.2010.04.024. Full text. Human prospective birth comparison.
Zabaneh R et al. The effects of prenatal methamphetamine exposure on childhood growth patterns from birth to 3 years of age. American Journal of Perinatology. 2012;29(3):203–210. doi:10.1055/s-0031-1285094. Full text. Human longitudinal follow-up.